Private equity firm TA Associates has completed a significant minority investment in leading India-based infertility treatment provider INDIRA IVF .IVF is seen as a large and fast-growing opportunity in India, with a predicted 20% annual growth rate.
“IVF is a large and fast-growing opportunity in India that we believe has the ability to make a lasting positive impact on the lives of millions of people,” said TA Associates director Naresh Patwari. “We look forward to working with Dr. Ajay Murdia and the management team at Indira IVF to help them continue their growth efforts in India and in international markets, both organically and inorganically, and to help them offer additional adjacent clinical services.”
Research suggests that infertility affects 10-15% of married couples in India. Ernst & Young estimates that more than 25m couples actively seeking children in 2015 were suffering from infertility-related issues. Industry estimates suggest that there are 150,000-250,000 IVF cycles being done annually in India, and Ernst & Young expects the industry to grow at nearly 20% annually.